文献速递类风湿关节炎

新发类风湿关节炎的共病:一项双向随访的全国性病例对照研究

Comorbidity in incident rheumatoid arthritis: a nationwide case-control study with bidirectional follow-up.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

该研究基于波兰2011至2021年全国医疗索赔数据,采用回顾性病例对照设计,纳入新发类风湿关节炎患者15879例并按1:10匹配一般人群对照,在诊断前后各5年双向随访。结果显示类风湿关节炎与血液、肺、胃肠及心血管等多系统共病风险升高相关,其中间质性肺病和炎症性肠病关联最强。

要点

  • 新发类风湿关节炎患者诊断前后均存在多种共病风险升高,尤以血液、肺、胃肠和心血管疾病为著。
  • 类风湿关节炎与间质性肺病关联最强:诊断前IRR 2.97,诊断后IRR 4.66。
  • 诊断后甲状腺癌和淋巴瘤风险升高,而结肠癌风险降低。

核心结论

  • 类风湿关节炎诊断前后均观察到多种并发疾病风险升高,且不同疾病组模式各异。
  • 这些数据突显类风湿关节炎的多系统性质,并需进一步研究因果及双向关系。

研究设计与样本

  • 回顾性病例对照研究,数据来自波兰2011至2021年所有可获得的医疗索赔。
  • 分析现患类风湿关节炎262265例以评估疾病模式,并从一般人群按1:10抽样新发类风湿关节炎15879例及年龄、性别、地区匹配对照。
  • 暴露为新发类风湿关节炎,通过间隔重复索赔和处方识别;从诊断起进行双向五年随访。

主要发现

  • 类风湿关节炎与多种共病风险升高相关:血液系统IRR 1.80(95%CI 1.58, 2.05),肺部IRR 1.57(95%CI 1.53, 1.62),胃肠道IRR 1.53(95%CI 1.46, 1.60),心血管IRR 1.25(95%CI 1.22, 1.27)。
  • 间质性肺病:诊断前IRR 2.97(95%CI 2.20, 4.02),诊断后IRR 4.66(95%CI 3.91, 5.56)。
  • 炎症性肠病:诊断前IRR 1.61(95%CI 1.25, 2.07),诊断后IRR 2.12(95%CI 1.70, 2.63)。
  • 诊断后甲状腺癌风险升高IRR 1.29(95%CI 1.00, 1.66),淋巴瘤风险升高IRR 1.50(95%CI 1.20, 1.88),结肠癌风险降低IRR 0.77(95%CI 0.62, 0.94)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文结论指出需进一步研究因果及双向关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate the association between risk of different concurrent disorders and diagnosis of rheumatoid arthritis (RA) using a temporal approach. METHODS: Retrospective, case-control study. Data were extracted from all available healthcare claims for Poland between 2011-2021. Prevalent RA (n = 262 265) patients were examined to evaluate morbidity patterns. Incident RA (n = 15 879) and age-, sex- and region-matched controls were sampled 1:10 from the general population (GP). Exposure was new-onset RA identified by interspaced, repeat claims and prescription. Follow-up was performed in a bidirectional, five-year timeframe from RA diagnosis (Dx). RESULTS: RA is associated with enhanced risk of multiple concomitant disorders both pre- and post-Dx, especially hematologic (incidence rate ratio (IRR) 1.80, 95% CI 1.58, 2.05), pulmonary (IRR 1.57, 95% CI 1.53, 1.62), gastrointestinal (IRR 1.53, 95% CI 1.46, 1.60) and cardiovascular (IRR 1.25, 95% CI 1.22, 1.27) conditions. RA appears strongly associated with interstitial lung disease (pre-Dx IRR 2.97, 95% CI 2.20, 4.02; post-Dx IRR 4.66, 95% CI 3.91, 5.56) and inflammatory bowel disease (pre-Dx IRR 1.61, 95% CI 1.25, 2.07; post-Dx IRR 2.12, 95% CI 1.70, 2.63). Enhanced post-Dx risk of thyroid cancer (IRR 1.29, 95% CI 1.00, 1.66) and lymphoma (IRR 1.50, 95% CI 1.20, 1.88) was observed, in contrast to reduced risk of colon cancer (IRR 0.77, 95% CI 0.62, 0.94). CONCLUSION: Enhanced risk of multiple concurrent disorders was observed both pre- and post-RA Dx, with varying patterns across different disease groups. These data highlight the multisystemic nature of RA and warrant further research into causal, bidirectional relationships.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Batko B, Szeląg M, Krajewska-Włodarczyk M, et al. Comorbidity in incident rheumatoid arthritis: a nationwide case-control study with bidirectional follow-up. Rheumatology (Oxford). 2025. PMID: 39689029. doi:10.1093/rheumatology/keae670

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。